Delivery Order SPE2DE21D0017-SPE2D625F5J1Q
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $1,407.07 for BinaxNOW COVID-19 antigen test cards. This fixed-price contract with economic price adjustment was awarded on July 25, 2025, with an ultimate completion date of August 15, 2025, and will be performed in Lockhart, Florida. The award was issued without a set-aside designation, indicating open competition. Funding is provided through the Defense Logistics Agency...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order valued at $6,030.30 for BinaxNOW COVID-19 antigen test cards on July 31, 2025, with an ultimate completion date of August 21, 2025. The contract, which carries a fixed-price structure with economic price adjustment provisions, was awarded without a set-aside designation, indicating full and open competition. Performance will be executed in Lockhart, Florida, and the contract is funded through...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,005.05 on January 14, 2025, for BinaxNOW COVID-19 Antigen Cards. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain and is scheduled for completion by February 5, 2025. The contract will be performed at Abbott's facility in Lockhart, Florida. No set-aside designation was applied to this award, indicating it...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on August 18, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,206.06. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain and will be performed in Lockhart, Florida. The contract represents an open competition award with no set-aside designation and is scheduled for ultimate completion on September...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order award valued at $4,422.22 on July 30, 2025, for BinaxNOW COVID-19 antigen cards to be delivered to Lockhart, Florida. The contract employs a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, indicating open competition among qualified vendors. The Defense Logistics...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on April 23, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $21,106.05. This fixed-price contract with economic price adjustment was competitively awarded without set-aside designation and is funded by the Defense Logistics Agency (DLA) Medical Supply Chain. The ultimate completion date is May 14, 2025, and performance will take place in Lockhart, Florida. The...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment for COVID-19 test kits on August 7, 2025, with an ultimate completion date of August 18, 2025. The contract, issued without set-aside designation, is funded by the Defense Logistics Agency Medical Supply Chain and specifies performance at the contractor's facility in Lockhart, Florida. This delivery order represents a continuation of...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on July 14, 2025, for COVID-19 test kits under contract number 4568782066. The contract is a fixed-price delivery order with economic price adjustment provisions and will be performed in Lockhart, Florida, with an ultimate completion date of July 23, 2025. The award was made without set-aside designation, indicating open competition. Funding is provided through the...
- The U.S. government awarded a $1,206.06 delivery order contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the supply of BinaxNOW COVID-19 antigen test kits. The contract, awarded by the Defense Logistics Agency Troop Support Medical, has an ultimate completion date of October 16, 2024 and is structured as a fixed-price with economic price adjustment agreement. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products to...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order contract valued at $6,000 for COVID-19 test kits by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on September 16, 2025, with an ultimate completion date of September 25, 2025, utilizes a fixed-price structure with economic price adjustment provisions and was awarded without a set-aside designation, indicating full and open competition. Performance of this...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F5J1QDelivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,005.05 on April 30, 2025, for BinaxNOW COVID-19 antigen cards. This fixed-price contract with economic price adjustment has an ultimate completion date of May 20, 2025, and will be performed in Lockhart, Florida. The contract was awarded without a set-aside designation, indicating full and open competition. Funding originates from the Defense Logistics Agency's Medical Supply Chain, which procures medical diagnostic products and testing supplies for federal healthcare facilities across the Department of Defense and other defense-related agencies. This delivery order represents a continuation of Abbott Rapid DX North America LLC's substantial role as a critical supplier of COVID-19 diagnostic products to federal government agencies. The company maintains multiple indefinite delivery vehicles, including Blanket Purchase Agreements with various Veterans Integrated Service Networks for BinaxNOW test kits and other point-of-care diagnostic services. The relatively modest ceiling value of this particular delivery order reflects the transaction-based nature of purchase orders placed against larger standing agreements that enable federal agencies to efficiently procure testing supplies and diagnostics on an as-needed basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/30/25 |